10th European Congress on Perspectives in Lung Cancer, Brussels

Published: March 6, 2009, midnight

b'Silvia Novello and Giorgio Scagliotti on harnessing insulin-like growth factor receptor inhibition in a Phase II study that showed clinical activity of figitumumab to be at least as good as that of inhibitors of other growth factors already being used in cancer.'